|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- For-Profit Hospitals Associated With Higher AMI Readmission RatesFor-profit hospitals had higher 30-day nonelective acute myocardial infarction (AMI) readmission rates and patients treated at these facilities were more likely to experience renal and respiratory complications at readmission and nonhome discharge, according to a recent study published in JACC: Advances.
- HF Commentaries: Adipokine Hypothesis For CpcPH-HFpEF; AI in EHR AnalysisTreating elevated pulmonary vascular resistance (PVR) alone in patients with heart failure with preserved ejection fraction (HFpEF) and combined postcapillary and precapillary pulmonary hypertension (CpcPH-HFpEF) may target the wrong mechanism and only address downstream consequences...
- Higher Coronary Blood Flow in Women May Help Explain Delayed CAD PresentationWomen in the CENTURY trial had higher coronary blood flow (CBF) than men while having a comparable burden of cardiovascular risk factors, similar treatment response and half the coronary events, offering a potential physiological explanation for the delayed clinical manifestation of coronary artery disease (CAD) in women...
- CREST-2, CREST-H: Revascularization Does Not Improve Cognition in Asymptomatic Carotid StenosisFor patients with severe asymptomatic carotid artery stenosis, adding revascularization with either carotid artery stenting (CAS) or carotid endarterectomy (CEA) to intensive medical management (IMM) did not improve cognition compared with IMM alone...
- ATTR-CM: Concomitant Therapy and Vutrisiran Treatment Effect; New Disease Progression FrameworkConcomitant use of tafamidis or heart failure (HF) therapies did not modify the treatment benefit of vutrisiran on all-cause mortality and recurrent cardiovascular events, according to a HELIOS-B analysis recently published in JACC.



